Home / Latest Reports / Active Pharmaceutical Ingredients Api Market

Active Pharmaceutical Ingredients (api) Market By Type Of Synthesis, Type Of Manufacturer, Type And Application - Global Industry Analysis And Forecast To 2023

Published On : June 2022 Pages : 180 Category: Healthcare IT Report Code : HC06857

Request Sample Inquiry Before Buying Request for Customization Check Discount

Industry Outlook and Trend Analysis

The Active Pharmaceutical Ingredients (API) Market was worth USD 134.78 billion in 2017 and is expected to reach approximately USD 232.17 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 6.23% during the forecast period. The market development can be connected to the rising pervasiveness of chronic diseases, for example, cardiovascular diseases, neurological diseases, and cancer. Expanding interest for rapid-acting & efficient medications and presentation of innovative medication manufacturing offices are other key drivers evaluated to fuel development of this market over the figure time frame. Huge pharmaceutical players settling on API outsourcing from creating locales, for example, China, India, and Brazil are anticipated to give these districts potential development stage.

Synthesis Type Outlook and Trend Analysis

Based on synthesis, the market sorted into synthetic and biotech. Different methodologies are implemented by the manufacturers relying upon the complexity of the required molecule. Synthetic APIs are composed with an organic chemistry base as opposed to biotech APIs, which are made using molecular methods. Biotech portion is additionally grouped into recombinant proteins, monoclonal antibodies, and vaccines.

Manufacturer Type Outlook and Trend Analysis

Based on manufacturer type, it is characterized into captive or in-house and merchant or outsourced APIs. As per the market estimates, captive APIs was the biggest fragment in 2017 and the trader APIs are foreseen to be the quickest developing section over the figure time frame.

Type Outlook and Trend Analysis

Innovative medication fragment incorporates branded products though generic drugs are the ones accessible over the counter. Inferable from high prescription rate, high cost, and broad medication improvement activities, imaginative APIs overwhelmed the market in the year 2017. Besides, generics are required to be the quickest developing section writes over the figure time frame, by virtue of patent lapses of different blockbuster drugs.

Application Outlook and Trend Analysis

Cancer, neurological disorders, cardiovascular diseases and CNS, and endocrinal disorders are the major uses of API. Cardiovascular diseases commanded in 2017 inferable from its higher predominance rate and high measure of item accessibility. Heart diseases have been accounted for to be the main source of death in the U.S since numerous years.

Regional Outlook and Trend Analysis

North America ruled the general API market in 2017 and is foreseen to hold its position over the estimate time frame, attributable to the expanding R&D use, rising positive government activities for usage of bland medications and advancements in technology in the field of medication producing. Asia Pacific is anticipated to be the quickest developing over the figure time frame attributable to the accessibility of affordable labour.

Competitive Insights

The major players in the market are Cipla, AbbVie Inc, Merck & Co, Teva Pharmaceutical Industries and Boehringer Ingelheim. Acquisitions, new molecule launches, collaborations, and regional expansions are some of the efforts undertaken by these industry players to maintain a strong position.

The Active Pharmaceutical Ingredients (API) Market is segmented as follows-

By Type of Synthesis:

  • Vaccines
  • Biotech
    • Recombinant proteins
    • Monoclonal antibodies
  • Synthetic

By Type of Manufacturer:

  • Merchant APIs
  • Captive APIs

By Type:

  • Innovative APIs
  • Generic APIs

By Application:

  • Cardiovascular Disease
  • Oncology
  • CNS and Neurological Disorders
  • Orthopedic Disorders
  • Endocrinology
  • Pulmonology
  • Gastrointestinal Disorders
  • Nephrology
  • Ophthalmology
  • Other Applications

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Active Pharmaceutical Ingredients (API) Market, By Type of Synthesis, Estimates and Forecast, 2014-2023 ($Million)

·         Biotech

·         Synthetic

o    Monoclonal Antibodies

o    Recombinant Proteins

·         Vaccines

·         Active Pharmaceutical Ingredients (API) Market, By Type of Manufacturer, Estimates and Forecast, 2014-2023 ($Million)

·         Captive APIs

·         Merchant APIs

·         Active Pharmaceutical Ingredients (API) Market, By Type, Estimates and Forecast, 2014-2023 ($Million)

·         Generic APIs

·         Innovative APIs

·         Active Pharmaceutical Ingredients (API) Market, By Application, Estimates and Forecast, 2014-2023 ($Million)

·         Cardiovascular Disease

·         Oncology

·         CNS and Neurological Disorders

·         Orthopedic Disorders

·         Endocrinology

·         Pulmonology

·         Gastrointestinal Disorders

·         Nephrology

·         Ophthalmology

·         Other Applications

·         Active Pharmaceutical Ingredients (API) Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

o    North America

§  North America Active Pharmaceutical Ingredients (API) Market, By Country

o    U.S. Active Pharmaceutical Ingredients (API) Market

o    Canada Active Pharmaceutical Ingredients (API) Market

o    Mexico Active Pharmaceutical Ingredients (API) Market

o    Europe

§  Europe Active Pharmaceutical Ingredients (API) Market, By Country

o    Germany Active Pharmaceutical Ingredients (API) Market

o    UK Active Pharmaceutical Ingredients (API) Market

o    France Active Pharmaceutical Ingredients (API) Market

o    Russia Active Pharmaceutical Ingredients (API) Market

o    Italy Active Pharmaceutical Ingredients (API) Market

o    Rest of Europe Active Pharmaceutical Ingredients (API) Market

o    Asia-Pacific

§  Asia-Pacific Active Pharmaceutical Ingredients (API) Market, By Country

o    China Active Pharmaceutical Ingredients (API) Market

o    Japan Active Pharmaceutical Ingredients (API) Market

o    South Korea Active Pharmaceutical Ingredients (API) Market

o    India Active Pharmaceutical Ingredients (API) Market

o    Southeast Asia Active Pharmaceutical Ingredients (API) Market

o    Rest of Asia-Pacific Active Pharmaceutical Ingredients (API) Market

o    South America

§  South America Active Pharmaceutical Ingredients (API) Market

o    Brazil Active Pharmaceutical Ingredients (API) Market

o    Argentina Active Pharmaceutical Ingredients (API) Market

o    Columbia Active Pharmaceutical Ingredients (API) Market

o    South Africa Active Pharmaceutical Ingredients (API) Market

o    Rest of South America Active Pharmaceutical Ingredients (API) Market

o    Middle East and Africa

§  Middle East and Africa Active Pharmaceutical Ingredients (API) Market

o    Saudi Arabia Active Pharmaceutical Ingredients (API) Market

o    UAE Active Pharmaceutical Ingredients (API) Market

o    Egypt Active Pharmaceutical Ingredients (API) Market

o    Nigeria Active Pharmaceutical Ingredients (API) Market

o    South Africa Active Pharmaceutical Ingredients (API) Market

o    Rest of MEA Active Pharmaceutical Ingredients (API) Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Active Pharmaceutical Ingredients (API) Market, By Type of Synthesis

5.1.       Introduction

5.2.       Global Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Type of Synthesis (2017-2027)

5.2.1.  Global Active Pharmaceutical Ingredients (API) Sales and Sales Share by Type of Synthesis (2017-2027)

5.2.2.  Global Active Pharmaceutical Ingredients (API) Revenue and Revenue Share by Type of Synthesis (2017-2027)

5.3.       Biotech

5.3.1.  Global Biotech Sales and Growth Rate (2017-2027)

5.4.       Synthetic

5.4.1.  Global Synthetic Sales and Growth Rate By Type (2017-2027)

5.4.2.  Global Synthetic Sales and Growth Rate (2017-2027)

5.4.3.  Monoclonal Antibodies

5.4.3.1.    Global Monoclonal Antibodies Sales and Growth Rate (2017-2027)

5.4.4.  Recombinant Proteins

5.4.4.1.    Global Recombinant Proteins Sales and Growth Rate (2017-2027)

5.5.       Vaccines

5.5.1.  Global Vaccines Sales and Growth Rate (2017-2027)

6.       Active Pharmaceutical Ingredients (API) Market, By Type of Manufacturer

6.1.       Introduction

6.2.       Global Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Type of Manufacturer (2017-2027)

6.2.1.  Global Active Pharmaceutical Ingredients (API) Sales and Sales Share by Type of Manufacturer (2017-2027)

6.2.2.  Global Active Pharmaceutical Ingredients (API) Revenue and Revenue Share by Type of Manufacturer (2017-2027)

6.3.       Captive APIs

6.3.1.  Global Captive APIs Sales and Growth Rate (2017-2027)

6.4.       Merchant APIs

6.4.1.  Global Merchant APIs Sales and Growth Rate (2017-2027)

7.       Active Pharmaceutical Ingredients (API) Market, By Type

7.1.       Introduction

7.2.       Global Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Type (2017-2027)

7.2.1.  Global Active Pharmaceutical Ingredients (API) Sales and Sales Share by Type (2017-2027)

7.2.2.  Global Active Pharmaceutical Ingredients (API) Revenue and Revenue Share by Type (2017-2027)

7.3.       Generic APIs

7.3.1.  Global Generic APIs Sales and Growth Rate (2017-2027)

7.4.       Innovative APIs

7.4.1.  Global Innovative APIs Sales and Growth Rate (2017-2027)

8.       Active Pharmaceutical Ingredients (API) Market, By Type of Application

8.1.       Introduction

8.2.       Global Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Type of Application (2017-2027)

8.2.1.  Global Active Pharmaceutical Ingredients (API) Sales and Sales Share by Type of Application (2017-2027)

8.2.2.  Global Active Pharmaceutical Ingredients (API) Revenue and Revenue Share by Type of Application (2017-2027)

8.3.       Cardiovascular Disease

8.3.1.  Global Cardiovascular Disease Sales and Growth Rate (2017-2027)

8.4.       Oncology

8.4.1.  Global Oncology Sales and Growth Rate (2017-2027)

8.5.       CNS and Neurological Disorders

8.5.1.  Global CNS and Neurological Disorders Sales and Growth Rate (2017-2027)

8.6.       Orthopedic Disorders

8.6.1.  Global Orthopedic Disorders Sales and Growth Rate (2017-2027)

8.7.       Endocrinology

8.7.1.  Global Endocrinology Sales and Growth Rate (2017-2027)

8.8.       Pulmonology

8.8.1.  Global Pulmonology Sales and Growth Rate (2017-2027)

8.9.       Gastrointestinal Disorders

8.9.1.  Global Gastrointestinal Disorders Sales and Growth Rate (2017-2027)

8.10.    Nephrology

8.10.1.      Global Nephrology Sales and Growth Rate (2017-2027)

8.11.    Ophthalmology

8.11.1.      Global Ophthalmology Sales and Growth Rate (2017-2027)

8.12.    Other Applications

8.12.1.      Global Other Applications Sales and Growth Rate (2017-2027)

9.       Active Pharmaceutical Ingredients (API) Market, By Region

9.1.       Introduction

9.2.       Global Active Pharmaceutical Ingredients (API) Sales, Revenue and Market Share by Regions

9.2.1.  Global Active Pharmaceutical Ingredients (API) Sales by Regions (2017-2027)

9.2.2.  Global Active Pharmaceutical Ingredients (API) Revenue by Regions (2017-2027)

9.3.       North America Active Pharmaceutical Ingredients (API) by Countries

9.3.1.  North America Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.3.2.  North America Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2027)

9.3.3.  North America Active Pharmaceutical Ingredients (API) Sales by Countries (2017-2027)

9.3.4.  North America Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Countries (2017-2027)

9.3.5.  U.S.

9.3.5.1.    United States Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.3.5.2.    United States Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.6.  Canada

9.3.6.1.    Canada Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.3.6.2.    Canada Active Pharmaceutical Ingredients (API) Sales (Millions USD) and Growth Rate (2017-2027)

9.3.7.  Mexico

9.3.7.1.    Mexico Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.3.7.2.    Mexico Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.       Europe Active Pharmaceutical Ingredients (API) by Countries

9.4.1.  Europe Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.4.2.  Europe Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2027)

9.4.3.  Europe Active Pharmaceutical Ingredients (API) Sales by Countries (2017-2027)

9.4.4.  Europe Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Countries (2017-2027)

9.4.5.  Germany

9.4.5.1.    Germany Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.4.5.2.    Germany Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  UK

9.4.6.1.    UK Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.4.6.2.    UK Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  France

9.4.7.1.    France Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.4.7.2.    France Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Russia

9.4.8.1.    Russia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.4.8.2.    Russia Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.9.  Italy

9.4.9.1.    Italy Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.4.9.2.    Italy Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.10.      Rest of Europe

9.4.10.1. Rest of Europe Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.4.10.2. Rest of Europe Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.       Asia-Pacific

9.5.1.  Asia-Pacific Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2027)

9.5.3.  Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Countries (2017-2027)

9.5.4.  Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Countries (2017-2027)

9.5.5.  China

9.5.5.1.    China Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.5.5.2.    China Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  Japan

9.5.6.1.    Japan Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.5.6.2.    Japan Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.3.     

9.5.7.  Korea

9.5.7.1.    Korea Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.5.7.2.    Korea Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  India

9.5.8.1.    India Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.5.8.2.    India Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.9.  Southeast Asia

9.5.9.1.    Southeast Asia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.5.9.2.    Southeast Asia Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.10.      Rest of Asia-Pacific

9.5.10.1. Rest of Asia-Pacific Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.5.10.2. Rest of Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.       South America

9.6.1.  South America Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.6.2.  South America Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2027)

9.6.3.  South America Active Pharmaceutical Ingredients (API) Sales by Countries (2017-2027)

9.6.4.  South America Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Countries (2017-2027)

9.6.5.  Brazil

9.6.5.1.    Brazil Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.6.5.2.    Brazil Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Argentina

9.6.6.1.    Argentina Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.6.6.2.    Argentina Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.7.  Columbia

9.6.7.1.    Columbia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.6.7.2.    Columbia Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.8.  Rest of South America

9.6.8.1.    Rest of South America Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.6.8.2.    Rest of South America Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.       Middle East and Africa

9.7.1.  Middle East and Africa Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2027)

9.7.3.  Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Countries (2017-2027)

9.7.4.  Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Countries (2017-2027)

9.7.5.  Saudi Arabia

9.7.5.1.    Saudi Arabia Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.7.5.2.    Saudi Arabia Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  United Arab Emirates

9.7.6.1.    United Arab Emirates Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.7.6.2.    United Arab Emirates Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  Egypt

9.7.7.1.    Egypt Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.7.7.2.    Egypt Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Nigeria

9.7.8.1.    Nigeria Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.7.8.2.    Nigeria Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  South Africa

9.7.9.1.    South Africa Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.7.9.2.    South Africa Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.10.      Rest of Middle East and Africa

9.7.10.1. Rest of Middle East and Africa Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2017-2027)

9.7.10.2. Rest of Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue (Millions USD) and Growth Rate (2017-2027)

10.   Company Profiles

10.1.    AbbVie, Inc.

10.1.1.      Business Overview

10.1.2.      Product Portfolio

10.1.3.      Strategic Developments

10.1.4.      Sales, Revenue and Market Share

10.2.    Boehringer Ingelheim GmbH

10.2.1.      Business Overview

10.2.2.      Product Portfolio

10.2.3.      Strategic Developments

10.2.4.      Sales, Revenue and Market Share

10.3.    Bristol-Myers Squibb Company

10.3.1.      Business Overview

10.3.2.      Product Portfolio

10.3.3.      Strategic Developments

10.3.4.      Sales, Revenue and Market Share

10.4.    Cipla, Inc.

10.4.1.      Business Overview

10.4.2.      Product Portfolio

10.4.3.      Strategic Developments

10.4.4.      Sales, Revenue and Market Share

10.5.    Merck& Co., Inc.

10.5.1.      Business Overview

10.5.2.      Product Portfolio

10.5.3.      Strategic Developments

10.5.4.      Sales, Revenue and Market Share

10.6.    Albemarle Corporation

10.6.1.      Business Overview

10.6.2.      Product Portfolio

10.6.3.      Strategic Developments

10.6.4.      Sales, Revenue and Market Share

10.7.     Aurobindo Pharma

10.7.1.      Business Overview

10.7.2.      Product Portfolio

10.7.3.      Strategic Developments

10.7.4.      Sales, Revenue and Market Share

10.8.    Mylan N.V.

10.8.1.      Business Overview

10.8.2.      Product Portfolio

10.8.3.      Strategic Developments

10.8.4.      Sales, Revenue and Market Share

10.9.    Teva Active Pharmaceuticals Industries Ltd.

10.9.1.      Business Overview

10.9.2.      Product Portfolio

10.9.3.      Strategic Developments

10.9.4.      Sales, Revenue and Market Share

10.10.Sun Pharmaceutical Industries, Ltd.

10.10.1.  Business Overview

10.10.2.  Product Portfolio

10.10.3.  Strategic Developments

10.10.4.  Sales, Revenue and Market Share

11.   Global Active Pharmaceutical Ingredients (API) Market Competition, by Manufacturer

11.1.    Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Manufacturer (2017-2017)

11.2.    Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Manufacturer (2017-2017)

11.3.    Global Active Pharmaceutical Ingredients (API) Price by Manufacturer (2017-2017)

11.4.    Top 5 Active Pharmaceutical Ingredients (API) Manufacturer Market Share

11.5.    Market Competition Trend

12.   Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.1.    Global Active Pharmaceutical Ingredients (API) Sales, Revenue (Millions USD) and Growth Rate (2027-2023)

12.2.    Active Pharmaceutical Ingredients (API) Market Forecast by Regions (2027-2023)

12.2.1.      North America Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.1.1. United States Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.1.2. Canada Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.1.3. Mexico Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.2.      Europe Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.2.1. Germany Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.2.2. United Kingdom Active Pharmaceutical Ingredients (API)s Market Forecast (2027-2023)

12.2.2.3. France Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.2.4. Russia Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.2.5. Italy Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.2.6. Rest of the Europe Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.3.      Asia-Pacific Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.3.1. China Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.3.2. Japan Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.3.3. Korea Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.3.4. India Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.3.5. Southeast Asia Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.3.6. Rest of Asia-Pacific Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.4.      South America Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.4.1. Brazil Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.4.2. Argentina Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.4.3. Columbia Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.4.4. Rest of South America Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.5.      Middle East and Africa Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.5.1. Saudi Arabia Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.5.2. UAE Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.5.3. Egypt Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.5.4. Nigeria Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.5.5. South Africa Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.2.5.6. Rest of MEA Active Pharmaceutical Ingredients (API) Market Forecast (2027-2023)

12.3.    Active Pharmaceutical Ingredients (API) Market Forecast by Type of Synthesis (2027-2023)

12.3.1.      Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type of Synthesis (2027-2023)

12.3.2.      Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Type of Synthesis (2027-2023)

12.4.    Active Pharmaceutical Ingredients (API) Market Forecast by Type of Manufacturer (2027-2023)

12.4.1.      Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type of Manufacturer (2027-2023)

12.4.2.      Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Type of Manufacturer (2027-2023)

12.5.    Active Pharmaceutical Ingredients (API) Market Forecast by Type (2027-2023)

12.5.1.      Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2027-2023)

12.5.2.      Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Type (2027-2023)

12.6.      Active Pharmaceutical Ingredients (API) Market Forecast by Type of Application (2027-2023)

12.6.1.      Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type of Application (2027-2023)

12.6.2.      Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Type of Application (2027-2023)

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Active Pharmaceutical Ingredients (API) Market.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*